BIONTECH
OpenCalais Metadata: Ticker
OpenCalais Metadata: LegalName
Turkey in talks to buy more COVID-19 vaccines, says health minister
Talks are underway to increase the amount of COVID-19 vaccines to be delivered to Turkey, Health Minister Fahrettin Koca has said, adding that the country is also looking at alternatives to secure injections.
Turkey has already signed a deal to buy at least 50 million doses of an experimental vaccine being developed by China's Sinovac.
Turkish health minister evaluates locally made vaccine
Talks are underway to increase the amount of COVID-19 vaccines to be delivered to Turkey, Health Minister Fahrettin Koca has said, adding that the country is also looking at alternatives to secure injections.
Turkey has already signed a deal to buy at least 50 million doses of an experimental vaccine being developed by China's Sinovac.
FT selects vaccine founders Şahin, Türeci as People of the Year
The Financial Times has selected Turkish-German scientists Uğur Şahin and Özlem Türeci, who are at the helm of developing the world's first effective coronavirus vaccine, as 2020 People of the Year.
They are the symbol of a remarkable scientific and business success story, said the Financial Times.
UK to Spend 3.7 Billion Pounds on Vaccines and Will Take Liability for Claims
Britain has agreed to spend 3.7 billion pounds on Covid-19 vaccines and in most cases will bear the liability if claims are made against the pharmaceutical companies involved.
Balkan States Race to Secure COVID-19 Vaccine Supplies
Those that are self-financing will be guaranteed sufficient doses to protect a certain proportion of their population, depending on how much they buy into it; funded countries will receive enough doses to vaccinate up to 20 per cent of their population in the longer term.
The WHO says the programme represents "a huge success for multilateralism and cooperation."
US vaccinations ramp up as 2nd COVID-19 shot nears
Hundreds more hospitals around the country began dispensing COVID-19 shots to their workers in a rapid expansion of the U.S. vaccination drive on Dec. 15, while a second vaccine moved to the cusp of government authorization.
- Read more about US vaccinations ramp up as 2nd COVID-19 shot nears
- Log in to post comments
Explainer: Why is the EU taking so long to OK vaccine?
As Canadians, Britons and Americans begin getting immunized with a German-developed vaccine against coronavirus, pressure is building on the European Medicines Agency to approve the shot made by Pfizer Inc. and the German company BioNTech.
German officials have been especially vocal that they want it approved before Christmas. Here's a look at the EMA approval process:
EU Medicines Agency Will Approve First Vaccine on 23 December
The European Medicines Agency (EMA) is set to approve its first COVID-19 vaccine on Dec. 23, a German government source told Reuters on Tuesday, putting EU countries on track to start to catch up with the United States and Britain, where immunisation campaigns are under way.
First Covid vaccinations in EU likely this year, EU Commission head says
European Union countries could begin coronavirus inoculations as soon as this year, the head of the European Commission said on Tuesday.
This followed the EU drug regulator's decision to bring forward its possible approval of the Pfizer/BioNTech coronavirus vaccine to Dec. 21.
Germany says EU agency will OK coronavirus vaccine by December 23
After days of pressuring the European Union's medical regulator, Germany's health minister said Tuesday that he has received assurances that the European Medicines Agency will approve a coronavirus vaccine by December 23.